| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/18/2010 | WO2009020565A8 Use of phosphatases to treat neuroblastomas and medulloblastomas |
| 02/18/2010 | WO2009012569A8 TREATING OR AMELIORATING A NEUROINFLAMMATORY OR DEMYELINATING DISORDER WITH PROLACTIN AND INTERFERON-β |
| 02/18/2010 | WO2008135963A3 Fibrinogen for treatment of bleeding in trauma and platelet disorders |
| 02/18/2010 | WO2008132712A3 Combination pharmaceutical compositions |
| 02/18/2010 | US20100042037 System and Method for Collecting Plasma Protein Fractions from Separated Blood Components |
| 02/18/2010 | US20100041868 Conserved neisserial antigens |
| 02/18/2010 | US20100041867 Reversible pegylated drugs |
| 02/18/2010 | US20100041639 Cyclic malonamides as inhibitors of a beta protein production |
| 02/18/2010 | US20100041615 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 02/18/2010 | US20100041614 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 02/18/2010 | US20100041613 Novel antibiotic compositions |
| 02/18/2010 | US20100041612 Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
| 02/18/2010 | US20100041611 Rapid Isolation of Osteoinductive Protein Mixtures From Mammalian Bone Tissue |
| 02/18/2010 | US20100041610 Insecticidal toxin complex fusion protiens |
| 02/18/2010 | US20100041609 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 02/18/2010 | US20100041608 Method for stimulating wound healing |
| 02/18/2010 | US20100041607 Unctuous compositions |
| 02/18/2010 | US20100041606 Methods of Use of Eggshell Polypeptides |
| 02/18/2010 | US20100041605 Use of VEGF-C or VEGF-D in Reconstructive Surgery |
| 02/18/2010 | US20100041604 Novel antiviral peptides against influenza virus |
| 02/18/2010 | US20100041603 Method of Promoting Wound Healing |
| 02/18/2010 | US20100041602 Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules |
| 02/18/2010 | US20100041601 Use of VEGF and homologues to treat neuron disorders |
| 02/18/2010 | US20100041600 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects |
| 02/18/2010 | US20100041599 Compositions and methods for bone formation, bone remodeling and toxin protection |
| 02/18/2010 | US20100041598 Use of Prolactin in the Prophylactic Treatment of Cancer |
| 02/18/2010 | US20100041597 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/18/2010 | US20100041596 Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors |
| 02/18/2010 | US20100041595 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof |
| 02/18/2010 | US20100041594 Use of Aplidine for the Treatment of Pancreatic Cancer |
| 02/18/2010 | US20100041593 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 02/18/2010 | US20100041592 Use of Amphiphilic Biocompatible Polymers for Solubilization of Hydrophobic Drugs |
| 02/18/2010 | US20100041591 Hcv protease inhibitors and uses thereof |
| 02/18/2010 | US20100041590 Compounds |
| 02/18/2010 | US20100041589 Methods for preparing purified lipopeptides |
| 02/18/2010 | US20100041588 Derivatives of apf and methods of use |
| 02/18/2010 | US20100041587 Combination therapy for inhibition of platelet aggregation |
| 02/18/2010 | US20100041586 Method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 02/18/2010 | US20100041585 Use of oritavancin for prevention and treatment of anthrax |
| 02/18/2010 | US20100041584 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery |
| 02/18/2010 | US20100041151 Compositions and methods for treating lysosomal storage disease |
| 02/18/2010 | US20100041147 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 02/18/2010 | US20100041144 Mammalian Cytokine; Related Reagents |
| 02/18/2010 | US20100041142 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 02/18/2010 | US20100041138 IL-17 homologous polypeptides and therapeutic uses thereof |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100041075 Tuberculosis Diagnostic Test |
| 02/18/2010 | US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide |
| 02/18/2010 | US20100041028 Zinc finger binding domains for GNN |
| 02/18/2010 | US20100041010 soaking the tissue in a cold stabilizing first solution, then in a polyether, salt, hydrogen peroxide and phosphate buffer second solution, in an alcohol and water to remove residues of the first solution and in a third solution of an antiinflammatory agent, an anticoagulant, alcohol and water |
| 02/18/2010 | US20100040714 Asthma/Allergy Therapy that Targets T-lymphoctyes and/or Eosinophils |
| 02/18/2010 | US20100040711 Zinc-carnosine -based treatment for non ulcer (functional ) dyspepsia & irritable bowel syndrome in humans and other animals |
| 02/18/2010 | US20100040710 Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. |
| 02/18/2010 | US20100040706 Method of anti-ageing cosmetic care by stimulation of survivin expression |
| 02/18/2010 | US20100040695 Methods for providing nutritional products for customized energy intake |
| 02/18/2010 | US20100040693 Silica capsules having nano-holes or nano-pores on their surfaces and method for preparing the same |
| 02/18/2010 | US20100040688 Hydrogel microparticle formation in aqueous solvent for biomedical applications |
| 02/18/2010 | US20100040686 Biomaterial |
| 02/18/2010 | US20100040676 Polycistronic hiv vector constructs |
| 02/18/2010 | US20100040675 Compositions and methods for promoting or inhibiting angiogenesis |
| 02/18/2010 | US20100040668 Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof |
| 02/18/2010 | US20100040664 Aabb-poly(depsipeptide) biodegradable polymers and methods of use |
| 02/18/2010 | US20100040662 Fixation Devices For Tissue Repair |
| 02/18/2010 | US20100040645 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent |
| 02/18/2010 | US20100040641 Peptide vaccines for cancers expressing tumor-associated antigens |
| 02/18/2010 | US20100040639 Methods of inducing il-10 production |
| 02/18/2010 | US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists |
| 02/18/2010 | US20100040634 Methods and compositions for modulating hgf/met |
| 02/18/2010 | US20100040632 Composition |
| 02/18/2010 | US20100040631 Combination Therapy of HIV Using Fusion/Entry Inhibitors Targeting GP41 |
| 02/18/2010 | US20100040628 Indoprofen derivatives for promoting bone growth |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040626 Methods for detecting and treating attention-deficit/hyperactivity disorder |
| 02/18/2010 | US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon |
| 02/18/2010 | US20100040623 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 02/18/2010 | US20100040622 Netrin-related compositions and uses |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040618 Prevention of tumors with monoclonal antibodies against neu |
| 02/18/2010 | US20100040617 Method of Using CD100 (or Sema4D) to Mediate Platelet Activation and Inflammatory Responses |
| 02/18/2010 | US20100040612 Methods and compositions for reducing amyloid beta levels |
| 02/18/2010 | US20100040609 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 02/18/2010 | US20100040608 Use of HMGB1 antagonists for the treatment of inflammatory skin conditions |
| 02/18/2010 | US20100040607 Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040603 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies |
| 02/18/2010 | US20100040602 Antibodies against Human Cytimegalovirus (HCMV) |
| 02/18/2010 | US20100040598 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 02/18/2010 | US20100040597 Thrombin mutant |
| 02/18/2010 | US20100040596 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 02/18/2010 | US20100040595 Xylanses for animal feed |
| 02/18/2010 | US20100040594 Formulations for nonsurgical exogenous crosslink therapy |
| 02/18/2010 | US20100040593 Formulations for nonsurgical exogenous crosslink therapy |
| 02/18/2010 | US20100040592 Lipase-containing composition and methods of use thereof |
| 02/18/2010 | US20100040591 Native potato protein isolates |
| 02/18/2010 | US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules |
| 02/18/2010 | US20100040583 Compositions and methods using stem cells in cutaneous wound healing |
| 02/18/2010 | US20100040581 Epo derivative-containing therapeutic agents for blood-related diseases |
| 02/18/2010 | US20100040577 METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS |
| 02/18/2010 | US20100040576 Modified Oligonucleotides For The Treatment Of Hepatitis C Infection |
| 02/18/2010 | US20100040575 Use of inhibitors of glutaminyl cyclase and glutamate cyclase for treatment and prevention of neurodegenerative diseases |